Loading...

Amgen Inc.

AMGN•NASDAQ
Healthcare
Drug Manufacturers - General
$344.55
$-4.07(-1.17%)
U.S. Market opens in 15h 23m

Amgen Inc. (AMGN) Stock Overview

Explore Amgen Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap185.7B
P/E Ratio24.20
EPS (TTM)$14.25
ROE0.97%
Fundamental Analysis

AI Price Forecasts

1 Month$367.82
3 Months$307.01
1 Year Target$339.70

AMGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Amgen Inc. (AMGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $339.70.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.20 and a market capitalization of 185.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.17%
5-Day Change
-2.09%
1-Month Change
-1.11%
3-Month Change
-0.06%
6-Month Change
18.09%
Year-to-Date (YTD) Change
5.27%
1-Year Change
23.12%
3-Year Change
40.95%
5-Year Change
34.84%
All-Time (Max) Change
100132.73%

Contact Information

https://www.amgen.com
805 447 1000
One Amgen Center Drive, Thousand Oaks, CA, 91320-1799

Company Facts

28,000 Employees
IPO DateJun 17, 1983
CountryUS
Actively Trading

Frequently Asked Questions